Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 30 04 2020
accepted: 06 08 2020
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 2 9 2020
Statut: epublish

Résumé

Current geographic spread of documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections shows heterogeneity. This study explores the role of age in potentially driving differentials in infection spread, epidemic potential, and rates of disease severity and mortality across countries. An age-stratified deterministic mathematical model that describes SARS-CoV-2 transmission dynamics was applied to 159 countries and territories with a population ≥1 million. Assuming worst-case scenario for the pandemic, the results indicate that there could be stark regional differences in epidemic trajectories driven by differences in the distribution of the population by age. In the African Region (median age: 18.9 years), the median R0 was 1.05 versus 2.05 in the European Region (median age: 41.7 years), and the median (per 100 persons) for the final cumulative infection incidence was 22.5 (versus 69.0), for severe and/or critical disease cases rate was 3.3 (versus 13.0), and for death rate was 0.5 (versus 3.9). Age could be a driver of variable SARS-CoV-2 epidemic trajectories worldwide. Countries with sizable adult and/or elderly populations and smaller children populations may experience large and rapid epidemics in absence of interventions. Meanwhile, countries with predominantly younger age cohorts may experience smaller and slower epidemics. These predictions, however, should not lead to complacency, as the pandemic could still have a heavy toll nearly everywhere.

Identifiants

pubmed: 32817662
doi: 10.1371/journal.pone.0237959
pii: PONE-D-20-12640
pmc: PMC7444586
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0237959

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Emerg Infect Dis. 2019 Jan;25(1):1-4
pubmed: 30560777
J Biol Dyn. 2012;6:590-611
pubmed: 22873607
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372753
Am J Epidemiol. 1997 Jun 15;145(12):1127-37
pubmed: 9199543
Influenza Other Respir Viruses. 2013 Sep;7(5):872-86
pubmed: 23331969
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
BMC Med. 2019 Mar 11;17(1):57
pubmed: 30853029
Nature. 2020 Mar;579(7800):482-483
pubmed: 32203366
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
J Med Virol. 2020 May 29;:
pubmed: 32470164
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
J Viral Hepat. 2017 Jun;24(6):486-495
pubmed: 28039923
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
PLoS One. 2015 Dec 30;10(12):e0145729
pubmed: 26716442
J Int AIDS Soc. 2014 Feb 21;17:18765
pubmed: 24560339
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
JAMA. 2020 Feb 24;:
pubmed: 32091533
Epidemics. 2014 Mar;6:1-9
pubmed: 24593916
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252

Auteurs

Houssein H Ayoub (HH)

Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.

Hiam Chemaitelly (H)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.

Shaheen Seedat (S)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York City, New York, United States of America.

Ghina R Mumtaz (GR)

Department of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.

Monia Makhoul (M)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York City, New York, United States of America.

Laith J Abu-Raddad (LJ)

Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York City, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH